NYSE:AIM | Free Cash Flow | AIM ImmunoTech Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$2.72M
2025-12-31-$1.99M
2025-03-31-$2.36M
2024-12-31-$3.96M$0.00-$3.96M
2024-03-31-$4.82M
2023-12-31-$9.76M
2023-03-31-$3.68M
2022-12-31-$6.07M
2022-03-31-$2.76M
2021-12-31-$5.75M$7,000.00-$5.75M
2021-03-31-$3.05M
2020-12-31-$2.85M$9,000.00-$2.86M
2020-03-31-$3.25M$7,000.00-$3.26M
2019-12-31-$2.29M$0.00-$2.29M
2019-03-31-$1.46M$14,000.00-$1.47M
2018-12-31-$2.42M$3,000.00-$2.42M
2018-03-31-$2.54M
2017-12-31-$760,000.00$0.00-$760,000.00
2017-03-31-$2.99M$3,000.00-$3M
2016-12-31-$2.1M$0.00-$2.1M
2016-03-31-$1.04M
2015-12-31-$3.31M$14,000.00-$3.33M
2015-03-31-$4.26M$47,000.00-$4.3M
2014-12-31-$4.03M$118,000.00-$4.15M
2014-03-31-$2.9M$65,000.00-$2.96M
2013-12-31-$3.18M$151,000.00-$3.34M
2013-03-31-$5.85M$244,000.00-$6.1M
2012-12-31-$4.96M$934,000.00-$5.89M
2012-03-31-$1.67M$1.55M-$3.22M
2011-12-31-$3.02M$953,000.00-$3.98M
2011-03-31-$1.82M$36,000.00-$1.85M
2010-12-31-$1.82M$215,000.00-$2.03M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$10.96M
2024-12-31-$14.89M$18,000.00-$14.91M
2023-12-31-$21.27M
2022-12-31-$16.11M$86,000.00-$16.19M
2021-12-31-$13.97M$41,000.00-$14.01M
2020-12-31-$10.37M$22,000.00-$10.39M
2019-12-31-$9.07M$68,000.00-$9.14M
2018-12-31-$10.64M$51,000.00-$10.69M
2017-12-31-$7.94M$20,000.00-$7.96M
2016-12-31-$7.38M$160,000.00-$7.54M
2015-12-31-$16.05M$240,000.00-$16.29M
2014-12-31-$13.96M$504,000.00-$14.47M
2013-12-31-$16.83M$898,000.00-$17.73M
2012-12-31-$13.14M$5.76M-$18.89M
2011-12-31-$10.1M$1.8M-$11.9M
2010-12-31-$11.89M$729,000.00-$12.62M
2009-12-31-$9.3M$332,000.00-$9.63M